← Return to the complete list of publications

Bringing a Leukemic Stem Cell Gene Signature into Clinics: Are We There Yet?

Richard-Carpentier G, Sauvageau G

The Leucegene Project at the Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3C 3J7, Canada; Banque de Cellules Leucémiques du Quebec, Maisonneuve-Rosemont Hospital, Montréal, QC H1T 2M4, Canada.

Prognostic markers that capture leukemia stem cell (LSC) activity can be useful for the risk stratification of acute myeloid leukemia (AML) patients. In a recent issue of Nature, Ng et al. (2016) develop a prognostic score based on a 17-gene expression signature of LSCs to predict outcome in AML patients.

Cell Stem Cell 2017;20(3):300-301.

Pubmed ID: 28257710

Follow IRIC

Logo UdeM